Indogulf Cropsciences Limited has informed the Exchange about Transcript
IGCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indogulf Cropsciences reported a strong Q1 FY26 with revenue of INR 1,894 million, up 43.3% year-on-year, driven by 73.4% growth in domestic B2B and 17% growth in B2C segments. EBITDA grew 66.7% YoY to INR 99 million and profit after tax more than tripled to INR 39 million (+187.4% YoY). Crop protection contributed over 90% of revenue, while the biologicals segment grew 24.1% and the new subsidiary brand 'Giraffe' (AGPL) contributed 6% of revenue. Management guided for 30-35% revenue growth in FY26 with similar aspiration for FY27-FY28, improving EBITDA margins, and stated that a new Unit 5 (including a dry flowable plant) will be commissioned this fiscal year, expanding capacity by 50-60% with peak sales potential of INR 1,700-2,000 crores.
Positive for shareholders — the company posted strong top-line and bottom-line growth, and management's guidance for 30-35% annual revenue growth with margin expansion signals confidence. However, the stock may react to the mixed signal that Q1 gross margins dipped 258 bps due to a higher B2B mix, though this is expected to reverse in Q2 when B2C and biologicals contribute more.